Company: ARTL
Filing Date: 2025-08-04
Form Type: 8-K
Source: 0001640334-25-001334
Chunk: 22

Company: ARTELO BIOSCIENCES, INC.
Filing Date: 2025-08-04
Form: 8-K
Item: Item 9.01
Chunk 22
---
Item 9.01

Financial Statements and Exhibits.

(d) Exhibits

  Exhibit No.      Description                                                                                                    
 ──────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────
          4.1      Form of Prefunded Warrant                                                                                      
          4.2      Form of Market Priced Warrant                                                                                  
          4.3      Form of $50.00 Warrant                                                                                         
         10.1      Form of Securities Purchase Agreement by and between Artelo Biosciences, Inc. and the investors named therein  
         99.1      Press Release dated August 1, 2025                                                                             
         99.2      Press Release dated August 4, 2025                                                                             

  12  

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the Company has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

  Date: August 4, 2025      ARTELO BIOSCIENCES, INC.                                             
 ─────────────────────────────────────────────────────────────────────────────────────────────────
                            /s/ Gregory D. Gorgas                                                
                            Name:                         Gregory D. Gorgas                      
                            Title:                        Chief Executive Officer and President  

  13